...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Share transfer RBC

I was able to do so.  RBCDI are just putting road blocks upon road blocks on those who came after.  A new letter will be out friday I believe and hopefully it is FMV as opposed to FV.

Share
New Message
Please login to post a reply